Dow AgroSciences Identifies Lead Molecule in Collaboration with GVK Biosciences

Dow AgroSciences LLC, a wholly-owned subsidiary of The Dow Chemical Company today said that it had identified a new lead molecule for advancement with its Hyderabad-based research partner GVK Biosciences.

This newly identified lead compound has been selected for its ability to address a key product goal in support of Dow AgroSciences' growing agricultural chemicals business.

The discovery research agreement with GVK BIO began in May 2008 to generate novel molecules for synthesis and testing as fungicides and insecticides.

The two companies have benefited from the depth of expertise in medicinal chemistry and chemoinformatics at GVK BIO in combination with Dow AgroSciences' agricultural chemical capabilities.

"We are very pleased to reach this important milestone with GVK Bio under this collaborative discovery alliance," said Daniel R Kittle, PhD, vice president of research and development at Dow AgroSciences. "As we continue to invest in our strong agricultural chemicals business, we're building partnerships with some of the world's best research teams to discover creative new solutions in crop protection."

"The collaboration validates GVK BIO's ability and leadership in discovery programs and specifically our expertise in agro-chemical research. We are delighted with the outcome of the lead molecule and attribute it to the significant collaborative efforts of the GVK BIO and Dow teams," said Manni Kantipudi, CEO, GVK Biosciences.

 GVK Bio provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Its discovery expertise is spread ac ross chemistry, biology and informatics; and development services include clinical research, clinical pharmacology and process R&D. the company has a portfolio of around  150 customers includes big pharma, leading biotech, agro, life-sciences companies and top-notch academic institutions.

Dow AgroSciences LLC is an agricultural company providing with a strong global focus on agrochemical and biotechnology. The company, a wholly owned subsidiary of The Dow Chemical Company, has sales of $4.5 billion.